Myungshin Kim Selected Research

Myungshin Kim Research Topics

Disease

19	Neoplasms (Cancer) 11/2021 - 01/2003
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2022 - 01/2004
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2003
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2024 - 01/2002
9	Multiple Myeloma 06/2023 - 12/2007
7	Infections 01/2023 - 04/2005
7	Leukemia 01/2021 - 01/2004
6	Disease Progression 04/2017 - 04/2005
5	Sepsis (Septicemia) 01/2021 - 03/2015
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2020 - 02/2008
4	Inflammation (Inflammations) 10/2023 - 01/2006
4	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 01/2013
4	Chromosome Aberrations (Chromosome Abnormalities) 12/2014 - 01/2005
3	Paraproteinemias (Monoclonal Gammopathy) 09/2022 - 05/2014
3	Residual Neoplasm 01/2022 - 02/2008
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2006
3	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 03/2014
2	Blast Crisis (Blast Phase) 11/2022 - 03/2014
2	Philadelphia Chromosome 01/2021 - 11/2012
2	Optic Atrophy 10/2020 - 10/2014
2	Mucositis 09/2020 - 10/2015
2	Invasive Fungal Infections 02/2020 - 10/2015
2	Diarrhea 10/2015 - 01/2006
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2015 - 01/2008
2	Trisomy (Trisomies) 12/2014 - 06/2006
2	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 11/2014 - 05/2012
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 08/2014 - 03/2014
2	Thrombocytopenia (Thrombopenia) 07/2009 - 01/2007
2	Peripheral Nervous System Diseases (PNS Diseases) 07/2009 - 12/2007
2	Carcinoma (Carcinomatosis) 01/2004 - 01/2003
1	Cardiomyopathies (Cardiomyopathy) 04/2024
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2024
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Vaginitis 10/2023
1	Ossification of Posterior Longitudinal Ligament 02/2023
1	Primary Myelofibrosis (Myelosclerosis) 01/2023
1	Dent disease 1 01/2023
1	Cytomegalovirus Infections (Inclusion Disease) 10/2022
1	Multiple Organ Failure (MODS) 10/2022
1	Immunoglobulin G4-Related Disease 09/2022
1	Heart Failure 07/2022
1	Myocardial Infarction 07/2022
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 04/2022

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 10/2023 - 01/2006
9	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 04/2005
6	Biomarkers (Surrogate Marker)IBA 03/2021 - 06/2008
5	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2005
4	Tyrosine Kinase InhibitorsIBA 03/2024 - 01/2022
4	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2013
4	Nonsense Codon (Nonsense Mutation)IBA 10/2021 - 07/2017
4	Bortezomib (Velcade)FDA Link 01/2015 - 01/2007
4	Imatinib Mesylate (Gleevec)FDA Link 03/2014 - 05/2006
3	Mitochondrial DNA (mtDNA)IBA 10/2020 - 10/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2015
3	Interleukin-5 (Interleukin 5)IBA 09/2018 - 01/2006
3	Interleukin-10 (Interleukin 10)IBA 09/2018 - 01/2006
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2018 - 01/2005
2	Blood Proteins (Serum Proteins)IBA 09/2022 - 09/2022
2	Transforming Growth Factor-beta Type II ReceptorIBA 01/2022 - 03/2013
2	Circulating Tumor DNAIBA 11/2021 - 08/2021
2	Carcinoembryonic AntigenIBA 05/2020 - 01/2003
2	posaconazole FDA Link 02/2020 - 10/2015
2	Hemoglobins (Hemoglobin)IBA 03/2019 - 07/2013
2	GlobinsIBA 03/2019 - 01/2019
2	Interleukin-9 (Interleukin 9)IBA 01/2019 - 09/2018
2	Interleukin-22 (IL-22)IBA 01/2019 - 09/2018
2	Interleukin-4 (Interleukin 4)IBA 09/2018 - 01/2006
2	EnzymesIBA 03/2017 - 10/2015
2	Phosphotransferases (Kinase)IBA 01/2016 - 05/2006
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 07/2009
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 05/2015 - 10/2003
2	N 30IBA 03/2015 - 01/2006
2	DNA ProbesIBA 12/2014 - 06/2006
2	AntigensIBA 05/2014 - 02/2008
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2013 - 10/2006
2	SolutionsIBA 11/2012 - 01/2002
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2010 - 01/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2007 - 01/2006
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2005 - 01/2004
1	AnthracyclinesIBA 04/2024
1	daratumumabIBA 06/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2023
1	Ferritins (Ferritin)IBA 02/2023
1	ChloridesIBA 01/2023
1	fms-Like Tyrosine Kinase 3IBA 12/2022
1	Antiviral Agents (Antivirals)IBA 10/2022
1	Foscarnet FDA LinkGeneric 10/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 10/2022
1	Cidofovir (Vistide)FDA Link 10/2022
1	Leflunomide (Arava)FDA LinkGeneric 10/2022
1	Immunoglobulin G (IgG)IBA 09/2022

Therapy/Procedure

14	Therapeutics 04/2024 - 01/2004
10	Drug Therapy (Chemotherapy) 04/2024 - 01/2004
6	Cell Transplantation 01/2023 - 02/2008
6	Stem Cell Transplantation 11/2020 - 01/2002
5	Hematopoietic Stem Cell Transplantation 01/2022 - 03/2015
3	Transplantation 01/2021 - 02/2008
2	Aftercare (After-Treatment) 04/2024 - 03/2014
2	Remission Induction 02/2020 - 01/2020
1	Pessaries 10/2023